Key statistics
On Friday, Phathom Pharmaceuticals Inc (PHAT:NSQ) closed at 12.56, -31.40% below its 52-week high of 18.31, set on Dec 23, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 13.53 |
|---|---|
| High | 13.76 |
| Low | 12.32 |
| Bid | 12.01 |
| Offer | 13.10 |
| Previous close | 13.56 |
| Average volume | 1.19m |
|---|---|
| Shares outstanding | 78.80m |
| Free float | 74.25m |
| P/E (TTM) | -- |
| Market cap | 989.71m USD |
| EPS (TTM) | -3.81 USD |
Data delayed at least 15 minutes, as of Feb 27 2026 21:00 GMT.
More ▼
- Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
- Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
- Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026
- Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026
- Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
- Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
- Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
- Phathom Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)
- Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
- Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
More ▼
